SK7-33113-66429
4 vaccinations
2 coded responses
38 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 152 / PA
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Registered in v-safe
-
2021-03-31
Dose 1 — Pfizer-BioNTech
- 2021-03-31
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-02
- 2021-04-03
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-14
-
2021-04-21
Dose 2 — Pfizer-BioNTech
-
2021-04-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-04-28
Health check-in — day 7, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-06-02
- 2021-07-21
- 2021-10-20
-
2021-12-06
Dose 3 — Pfizer-BioNTech
-
2021-12-06
Health check-in — day 0, dose 3Feeling: Fair · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-12-07
- 2021-12-08
- 2021-12-10
-
2021-12-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-13
- 2021-12-20
- 2021-12-27
- 2022-01-03
- 2022-01-12
-
2022-01-17
Survey response — day 42, dose 3MedDRA: Upper-airway cough syndrome — Feeling: FairFree text: Post nasal dripMedDRA releases: 2024-11 · check-in free text available
- 2022-03-07
- 2022-06-06
-
2022-09-16
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-17
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-19
- 2022-09-20
- 2022-09-21
- 2022-09-22
- 2022-09-25
- 2022-12-19
-
2023-03-17
Survey response — 6 months, dose 4MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-17
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-03-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Pfizer-BioNTech | |
| 2 | 2021-04-21 | Pfizer-BioNTech | |
| 3 | 2021-12-06 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 successful
Free text
Release 10 — day 42, dose 3
Symptoms: Post nasal drip
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release